Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
0.589
-0.035 (-5.58%)
At close: Apr 28, 2026, 4:00 PM EDT
0.589
-0.001 (-0.10%)
After-hours: Apr 28, 2026, 6:43 PM EDT
Galmed Pharmaceuticals Market Cap
Galmed Pharmaceuticals has a market cap or net worth of $3.88 million as of April 28, 2026. Its market cap has increased by 84.62% in one year.
Market Cap
3.88M
Enterprise Value
-14.14M
1-Year Change
84.62%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since March 13, 2014, Galmed Pharmaceuticals's market cap has decreased from $145.70M to $3.88M, a decrease of -97.34%. That is a compound annual growth rate of -25.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 4.10M | - |
| Dec 31, 2025 | 4.10M | -14.58% |
| Dec 31, 2024 | 4.80M | 166.67% |
| Dec 29, 2023 | 1.80M | -85.71% |
| Dec 30, 2022 | 12.60M | -72.43% |
| Dec 31, 2021 | 45.70M | -30.44% |
| Dec 31, 2020 | 65.70M | -45.93% |
| Dec 31, 2019 | 121.50M | 23.23% |
| Dec 31, 2018 | 98.60M | -11.33% |
| Dec 29, 2017 | 111.20M | 185.13% |
| Dec 30, 2016 | 39.00M | -53.85% |
| Dec 31, 2015 | 84.50M | 42.98% |
| Dec 31, 2014 | 59.10M | -59.44% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pulmatrix | 4.93M |
| Revelation Biosciences | 4.35M |
| 60 Degrees Pharmaceuticals | 4.30M |
| VivoSim Labs | 4.23M |
| Alzamend Neuro | 4.22M |
| AIM ImmunoTech | 4.21M |
| Matinas BioPharma Holdings | 3.91M |
| Ensysce Biosciences | 3.84M |